Management of overactive bladder in women

被引：0

作者：

Peyronnet, B. ^{[1
]}

Rigole, H. ^{[2
]}

Damphousse, M. ^{[2
]}

Manunta, A. ^{[1
]}

机构：

[1] Hop Pontchaillou, Serv Urol, F-35000 Rennes, France

[2] CHU Rennes, Serv Med Phys & Reeduc, F-35000 Rennes, France

来源：

PROGRES EN UROLOGIE | 2015年 / 25卷 / 14期

关键词：

URINARY; TERMINOLOGY;

D O I：

10.1016/j.purol.2015.05.014

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Overactive bladder (OAB) is defined as urgency, with or without urge incontinence, usually with frequency and nocturia. OAB has been reported in 9 to 43% of female patients. It is usually idiopathic. The diagnosis is clinical but an initial work-up may be needed to exclude an underlying cause (bladder tumor, stone, cystitis, neurological disorder...) using urinary tract ultrasound, urine culture or cystoscopy. The initial assessment may also include a frequency-volume chart and urodynamics. Behavioral therapy is the first line treatment. In case of failure, antimuscarinics are recommended. Nowadays, three treatment options are available for OAB refractory to antimuscarinics: sacral neuromodulation, peripheral tibial nerve stimulation and intra-detrusor injections of botulinum toxin. Surgical procedures such as augmentation cystoplasty are very rarely required. (C) 2015 Elsevier Masson SAS. All rights reserved.

引用

页码：877 / 883

页数：7

共 12 条

[1]

Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052

[2] Translation and linguistic validation in classical Arabic of the Urinary Symptom Profile (USP) questionnaire [J].

Arabi, H. ;

Bendeddouche, I. ;

Khalfaoui, S. ;

Louardi, N. ;

Ameur, A. ;

Lebreton, F. ;

Amarenco, G. .

PROGRES EN UROLOGIE, 2013, 23 (04) :244-248

[3] Guidelines for the treatment of urinary incontinence in women with refractory idiopathic vesical hyperactivity using sacral neuromodulation [J].

Cardot, V. ;

Berlizot, P. ;

Le Normand, L. .

PROGRES EN UROLOGIE, 2010, 20 :S161-S169

[4] Urinary bladder drugs [J].

Caremel, R. ;

Cornu, J. -N. ;

Kerdraon, J. ;

Castel-Lacanal, E. ;

Bastide, C. ;

Bruyere, F. ;

Guy, L. ;

Karsenty, G. .

PROGRES EN UROLOGIE, 2013, 23 (15) :1271-1286

[5] Pharmacological treatment of idiopathic overactive bladder: A literature review [J].

Cornu, J. -N. ;

Haab, F. .

PROGRES EN UROLOGIE, 2013, 23 (04) :227-236

[6] Pelvic floor rehabilitation for female urinary incontinence: Mechanisms of action [J].

Deffieux, X. ;

Billecocq, S. ;

Demoulin, G. ;

Rivain, A. -L. ;

Trichot, C. ;

Thubert, T. .

PROGRES EN UROLOGIE, 2013, 23 (08) :491-501

[7]

Game X, 2015, PROG UROL

[8] Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline [J].

Gormley, E. Ann ;

Lightner, Deborah J. ;

Burgio, Kathryn L. ;

Chai, Toby C. ;

Clemens, J. Quentin ;

Culkin, Daniel J. ;

Das, Anurag Kumar ;

Foster, Harris Emilio, Jr. ;

Scarpero, Harriette Miles ;

Tessier, Christopher D. ;

Vasavada, Sandip Prasan .

JOURNAL OF UROLOGY, 2012, 188 (06) :2455-2463

[9]

Haab F, 2004, PROG UROL, V14, P1103

[10] Guidelines for practical usage of botulinum toxin type A (BoNTA) for refractory idiopathic overactive bladder management [J].

Hermieu, J. -F. ;

Ballanger, P. ;

Amarenco, G. ;

Chartier-Kastler, E. ;

Cosson, M. ;

Costa, P. ;

Fatton, B. ;

Deffieux, X. ;

Denys, P. ;

Game, X. ;

Haab, F. ;

Karsenty, G. ;

Le Normand, L. ;

Ruffion, A. ;

Saussine, C. .

PROGRES EN UROLOGIE, 2013, 23 (17) :1457-1463

← 1 2 →